&nbsp;

Oct 2025

Drug

venetoclax

Other Name(s): Venclexta®

Quick Link(s):

Aug 2025

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Drug

midostaurin

Other Name(s): Rydapt®

Quick Link(s):

Jun 2025

Regimen

CISPGEMC(W)

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Drugs Used:

CISplatin,

gemcitabine

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

CISPPACL

Cancer Type:

Gynecologic,

Ovary

Intent: Adjuvant, Palliative

Drugs Used:

PACLitaxel,

CISplatin

Quick Link(s):

Regimen Monograph

Aug 2021

Regimen

CYCLTOPO

Cancer Type:

Sarcoma,

Ewing's,

Soft Tissue

Intent: Palliative

Drugs Used:

cyclophosphamide,

topotecan

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

DASA

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

daSAtinib - Ph+ CML in the chronic phase, with specific criteria

Exceptional Access Program

daSAtinib - Accelerated phase or blast phase Ph+ CML with documented resistance or intolerance to imatinib, with specific criteria

Drugs Used:

daSATinib

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

DCRB

Cancer Type:

Sarcoma,

Soft Tissue,

Skin,

Melanoma

Intent: Palliative

Drugs Used:

dacarbazine

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

EPIRIFOS

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Adjuvant

Drugs Used:

mesna,

Quick Link(s):

Regimen Monograph

Mar 2021

Regimen

EXEM

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

exemestane

Drugs Used:

exemestane

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

EXEM

Cancer Type:

Breast,

Gynecologic,

Endometrial

Intent: Palliative

Funding:

ODB - General Benefit

exemestane

Drugs Used:

exemestane